Ustekinumab
Ustekinumab (Stelara®) is a biologic drug that blocks two proteins, IL-12 and IL-23, which helps reduce inflammation that is associated with inflammatory arthritis.
Which conditions is it used to treat?
This drug is used to treat plaque psoriasis in adults and children aged twelve and older, and psoriatic arthritis (PsA) in adults.
How is it administered?
Ustekinumab is usually given as an injection under the skin (subcutaneous injection) at the first appointment, then again one month later, and then every three months thereafter.
Are there any situations where this drug wouldn’t be prescribed?
Ustekinumab may not be recommended if you have an active or serious infection (including tuberculosis), a history of recurring infections, or recent exposure to TB, as treatment could worsen these conditions. It is also unsuitable for people who have had severe allergic reactions to the drug, certain recent vaccinations like BCG, or those who need live vaccines. Caution is advised if you have a history of cancer, skin cancer risk factors, or heart disease. Additionally, it may not be appropriate during pregnancy or breastfeeding due to uncertain effects on the baby.
How long does this drug take to start working?
It can take between three weeks and three months to feel the benefit of ustekinumab.
What are the most common side-effects and risks?
Because it affects the immune system, ustekinumab can increase the risk of infection. Upper respiratory infections (e.g. colds, sore throat, sinus infections), headaches and tiredness (fatigue) can occur. Contact a doctor immediately if you develop symptoms such as fever, persistent cough, night sweats, shortness of breath, painful or blistering skin, burning when urinating, or diarrhoea. Other side-effects can include injection site reactions (such as redness, swelling, pain, or itching). Less commonly, some people may also get mild gastrointestinal symptoms or minor skin infections. Ustekinumab could potentially slightly increase the risk of certain cancers, particularly skin cancer. Patients with current or past skin cancer risk factors should report any new skin growths to their doctor and should always follow sun safe guidelines.
How do I reduce my risk of infection?
Tips to help reduce the risk of infection include;
- Washing hands regularly and thoroughly.
- Carrying anti-bacterial hand gel with you wherever you go.
- Keeping your oral hygiene good by regular brushing of teeth and gums.
- Keeping surface in your house clean and hygienic.
- Ensuring you store and prepare food according to high food hygiene standards.
- Stopping smoking if you currently smoke.
Will I need any special health checks before or while taking this drug?
Before you start ustekinumab you will have blood tests and a screening to check whether you have active tuberculosis (TB) or hepatitis. Some patients may need a course of treatment for latent (asymptomatic) TB before starting ustekinumab. You may have further blood tests while you are on ustekinumab to monitor its effects, and you may be recommended to also have a chest X-ray in some situations.
Drug Treatments & Arthritis
Inform yourself about all forms of arthritis medications by reading our booklet, giving you access to the most important information relating to the main drugs used to treat arthritis, as well as questions to ask your healthcare provider when deciding on medications.
Support Our Mission
Your donation helps us provide essential support, fund research, and improve the lives of those living with arthritis. Every contribution matters — help us make a difference today.